INTRODUCTION {#sec1-1}
============

Traditional Chinese medicine (TCM) has a robust history with roots dating back thousands of years for the medicinal practice in China and some East Asian countries.\[[@ref1]--[@ref3]\] Fructus Gardeniae, a commonly used TCM called Zhizi in chinese, is derived from the dried fruit of *Gardenia jasminoides* Ellis of the Madder Family.\[[@ref4]--[@ref7]\] The crude Fructus Gardeniae and its processed products of chaozheng pin (CZP) have been used clinically over 2000 years for purging heat to clear away disturbing in the mind, reducing fever to induce urination, and cooling blood to remove pathogenic heat.\[[@ref8][@ref9]\]

In the last decades, Fructus Gardeniae has been extensively investigated in phytochemistry, and the results indicated that geniposide, chlorogenic acid, crocin1, and rutin were the main active components in Fructus Gardeniae.\[[@ref10]\] To our knowledge, previously reported analytical methods were not developing for simultaneous determination of geniposide, chlorogenic acid, crocin1, and rutin in Fructus Gardeniae and CZP extracts. In this study, a HPLC method was developed for simultaneous determination four major active components in Fructus Gardeniae distributed in south of China. [Figure 1](#F1){ref-type="fig"} illustrates the structures of the four major active components their contents are considerable in Fructus Gardeniae.

![The chemical structures of four active components in Fructus Gardeniae](PM-7-267-g001){#F1}

MATERIALS AND METHODS {#sec1-2}
=====================

Materials and reagents {#sec2-1}
----------------------

Fructus Gardeniae was collected from four suppliers (Henan, Jiangxi, Zhejiang in China). Reference standards of geniposide, chlorogenic acid, crocin1, and rutin were purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). The purity for each standard compound was greater than 98% by HPLC analysis. All reagents with high grade were obtained from others. Milli-Q water (Millipore, Bedford, MA, USA) was used throughout the study.

Preparation of sample solutions {#sec2-2}
-------------------------------

The powder of Fructus Gardeniae samples quantitatively (0.1 g) transferred into dark brown calibrated flasks and extracted with 30 ml of 50% methanol in an ultrasonic bath for 30 min and cooled at room temperature; 50% methanol was added to compensate for the lost weight. The solution was filtered through a 0.45 μm membrane filter before subjecting 20 μl to HPLC analysis.

### Preparation of standard solutions and calibration curve {#sec3-1}

Standard stock solutions of rutin (0.004838 mg/ml), geniposide (1.54 mg/ml), chlorogenic acid (0.18 mg/ml), crocin1 (0.114mg/ml) were prepared in acetonitrile. Working standard solutions containing each of the four compounds were prepared by diluting the stock solution with acetonitrile to the proper volumes within the ranges, respectively. The standard stock and working solutions were all prepared in calibrated flasks and stored at 4°C. All calibration curves were constructed from peak areas of the reference standards versus their concentrations. The solutions were filtered through a 0.45 μm membrane prior to injection.

Chromatographis analysis {#sec2-3}
------------------------

Analyses were performed using HPLC system Agilent 1200 (Agilent Technologies, Palo Alto, CA, USA) with diode array detector. Detection wavelengths were set at 254 nm for rutin, 240 nm for geniposide, 330 nm for chlorogenic acid, and 440 nm for crocin1. An Agilent Zorbax Extend C~18~ (250 mm × 4.6 mm, 5 μm) was used with a flow rate of 1.0 ml/min. The injection volume was 20 μl and the column temperature was maintained at 25°C. Mobile phase was composed of (A) aqueous phosphoric acid (0.4%,v/v) and (B) acetonitrile using a gradient elution of 0\~45 min, 5%\~30% B; 45\~60 min, 30%\~50% B.

RESULTS AND DISCUSSION {#sec1-3}
======================

Optimization of HPLC chromatography conditions {#sec2-4}
----------------------------------------------

The aim of this study was to develop a HPLC method using DAD detection for simultaneous determination of geniposide, chlorogenic acid, crocin1, and rutin in Fructus Gardeniae and its CZP. Different mobile phase compositions were tested: (1) water-methanol; (2) water-acetonitrile; (3) aqueous phosphoric acid (0.1%, v/v)-acetonitrile; (4) aqueous ammonium acetate (0.5%, v/v)-acetonitrile; aqueous phosphoric acid (0.4%, v/v)-acetonitrile. As a result, the combination of aqueous phosphoric acid (0.4%, v/v)-acetonitrile for mobile phase was the best for separation. Furthermore, other chromatographic variables were also optimized, including analytical columns (Hanbon Hedera ODS-2, Hanbon Lichrospher C ~18~ and Agilent Zorbax Extend C ~18~ ), the column temperatures (20°C, 25°C, and 30°C) and the flow rates (0.8 ml/min and 1.0 ml/min). Eventually, the optimal separation was achieved on an Agilent Zorbax Extend C ~18~ column (250 mm × 4.6 mm, 5 μm) at a column temperature of 25°C with a flow rate of 1.0 ml/min. [Figure 2](#F2){ref-type="fig"} showed the typical separation of a standard mixture (a) and crude and processed Fructus Gardeniae extracts (b, c) obtained under the above optimized HPLC conditions.

![Typical chromatograms of reference compounds (a), crude drug (b), CZP (c), in different detection wavelengths. (1) chlorogenic acid; (2) Geniposide; (3) rutin; (4) crocin-1](PM-7-267-g002){#F2}

Calibration curves, limits of detection and quantification {#sec2-5}
----------------------------------------------------------

The working solutions containing all four reference compounds were prepared as described above to construct calibration curves. Each calibration curve contained five different concentrations and was performed in triplicate. An aliquot (20 μl) of each standard working solution was subjected to HPLC analysis. The regression equations were calculated in the form of y = ax + b, where y and x were peak area and concentration. The LOD was determined at a signal-to-noise ratio of 3, and the LOQ was determined as the lowest concentration in the linear range of each analyze. The regression equations (linear ranges) were y = 1075.6 x +5.7406 (1.32--2.464 mg/ml, geniposide), y = 395.4 x -2.1524 (0.144--0.324 mg/ml, chlorogenic acid), y = 5147.4 x + 5.3463 (0.0912--0.2052 mg/ml, crocin1), y = 28.815 x --0.4437 (0.0048--0.0109 mg/ml, rutin). All the marker substances showed good linearity (r^2^ ≥ 0.9999). The LOD and LOQ of the four analytes were 0.002--0.168 mg/ml and 0.0048--1.32 mg/ml, respectively.

Precision, repeatability and stability {#sec2-6}
--------------------------------------

The intra-day and inter-day precision was determined by analyzing calibration samples during a single day and on three different days, respectively. The intra-day variation was determined by analyzing the six replicates on the same day and inter-day variation was determined on three consecutive days. The relative standard deviation (RSD) was taken as a measure of precision, and overall intra-day and inter-day variations were less than 1.01%. To further evaluate the repeatability of the developed assay, Fructus Gardeniae was analyzed in six replicates as described above. The contents of four compounds in Fructus Gardeniae were calculated from the corresponding calibration curves. The relative standard deviations (R.S.D.s) were taken as measurements of repeatability. Stability was tested with Fructus Gardeniae at room temperature and analyzed at 0 h, 2 h, 4 h, 8 h, 12 h, 24 h, and 48 h within two days, respectively. The R.S.D.s of repeatability test and stability were not more than 3.01% for all analytes.

Accuracy {#sec2-7}
--------

Accuracy was determined by the recovery test. An appropriate amount of Fructus Gardeniae powder was weighed and spiked with known amount of each standard compound. They were then treated and analyzed as described above. Each sample was analyzed in six replicates. The total amount of each analyte was calculated from the corresponding calibration curve.

Recovery (%) = (Amount~determined~ --Amount~original~)/Amount~spiked~ × 100%.

Where Amount~determined~ is the determined total of each analyte, Amount~original~ is the original amount of each analyte in Fructus Gardeniae measured and Amount~spiked~ is the spiked amount of each analyte. The R.S.D. of recoveries of the analytes was less than 3.63%.

Sample analysis {#sec2-8}
---------------

The contents of geniposide, chlorogenic acid, crocin1, and rutin in Fructus Gardeniae samples analyzed were listed in [Table 1](#T1){ref-type="table"}. The results showed that the content of each compound in crude drug, CZP varied significantly. For instance, for Fructus Gardeniae collected from Zhejiang, the content of chlorogenic acid was lower in crude drug (0.16%), but higher in CZP (0.286%), crocin1 was hardly detected in CZP, but higher in crude drug (0.625%), the contents of geniposide in crude drug (4.242%) were higher than those in CZP (2.658%). The variations might result from different processing procedures for Fructus Gardeniae. It could also be seen that the total contents of four compounds varied slightly in the same type of samples from different suppliers which might be due to the differences in soils and climates in each region. Thus, it is necessary to control the main active components in Fructus Gardeniae by good agricultural practice (GAP) and the norm of Chinese medicinal materials processing.
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CONCLUSION {#sec1-4}
==========

An HPLC-DAD method has been developed to simultaneously determine geniposide, chlorogenic acid, crocin1, and rutin in crude and processed Fructus Gardeniae samples. This newly established method is validated as simple, precise, and accurate. It can be used as a valid analytical method for intrinsic quality control of Fructus Gardeniae.
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